The survival analysis showed that the patients with high expressions of GOT1, HNRNPA2B1, MAPK1, PAK2, UBE2N, and YWHAB showed shorter overall survival of PCa patients when compared to the low/intermediate expression of these proteins. This evidence concerns the gene MAPK1 and posterior cortical atrophy.